InvestorsHub Logo

Rkmatters

05/18/16 3:52 PM

#62132 RE: flipper44 #62131

Pretty amazing that IMUC changed their game plan after results as these. I do think though that they will be successful in gaining part of the GBM market. Not everyone will qualify for a resection. Plus there are other territories.

http://www.nwbio.com/nw-bio-responds-to-shareholder-inquiries-following-immune-therapy-sectors-recent-market-decline/